Swiss National Bank
SANA icon

Swiss National Bank’s Sana Biotechnology SANA Stock Holding History

Swiss National Bank’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$987K Buy
342,600
+6,800
+2% +$26.8K ﹤0.01% 2164
2025
Q4 		$1.37M Buy
335,800
+73,500
+28% +$329K ﹤0.01% 2038
2025
Q3 		$931K Buy
+262,300
New +$948K ﹤0.01% 2191
2025
Q2 		– Sell
-237,900
Closed -$400K – 2392
2025
Q1 		$400K Hold
237,900
– – ﹤0.01% 2372
2024
Q4 		$388K Hold
237,900
– – ﹤0.01% 2421
2024
Q3 		$990K Sell
237,900
-22,300
-9% -$117K ﹤0.01% 2221
2024
Q2 		$1.42M Buy
260,200
+66,100
+34% +$527K ﹤0.01% 1988
2024
Q1 		$1.94M Hold
194,100
– – ﹤0.01% 1849
2023
Q4 		$792K Buy
194,100
+6,600
+4% +$24.3K ﹤0.01% 2360
2023
Q3 		$726K Hold
187,500
– – ﹤0.01% 2400
2023
Q2 		$1.12M Buy
187,500
+2,300
+1% +$13.3K ﹤0.01% 2230
2023
Q1 		$606K Sell
185,200
-21,500
-10% -$85.9K ﹤0.01% 2477
2022
Q4 		$816K Buy
206,700
+6,500
+3% +$31.8K ﹤0.01% 2437
2022
Q3 		$1.2M Hold
200,200
– – ﹤0.01% 2232
2022
Q2 		$1.29M Buy
200,200
+110,900
+124% +$707K ﹤0.01% 2215
2022
Q1 		$738K Buy
89,300
+6,500
+8% +$52.6K ﹤0.01% 2508
2021
Q4 		$1.28M Buy
+82,800
New +$1.6M ﹤0.01% 2322

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Swiss National Bank's SANA Position: Q1 2026 in Review

Swiss National Bank increased its Sana Biotechnology (SANA) stake by 2% in Q1 2026, buying an estimated $26.8K and bringing the position to 342,600 shares worth $987K. The position accounts for ﹤0.01% of the portfolio, ranked #2164.

Swiss National Bank first reported a position in SANA in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.94M in Q1 2024. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Swiss National Bank held 342,600 shares of Sana Biotechnology worth $987K as of Q1 2026.
  • Swiss National Bank bought 6,800 Sana Biotechnology shares in Q1 2026, an estimated $26.8K.
  • Sana Biotechnology made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #2164 holding.
  • Swiss National Bank first reported a position in Sana Biotechnology in Q4 2021 and has held it in 17 quarters since.
  • Swiss National Bank's Sana Biotechnology position peaked at $1.94M in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.